FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
Letters to Industry / Healthcare Providers / Clinical InvestigatorsTherapeutic Biological Products
Letter to Abbott Laboratories Concerning Serious Manufacturing Deficiencies with Abbokinase -7/14/1999 (PDF), (Text)
Warning Letter - Abbokinase (Urokinase) - 3/19/1999 (PDF), (Text)
Dear Healthcare Provider: Important Drug Warning: Safety information regarding the use of Abbokinase (Urokinase) - 1/25/1999 - (PDF) - Updated information is provided in the March 16, 1999 Update on Abbokinase Information Sheet
Updated May 16, 2002
Back to Top Back to Index
Date created: September 25, 2003
CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page
FDA/Center for Drug Evaluation and Research